Need a specific person's email?
Browse Drug Development Institute's employee directory (about 6 employees) and reveal verified emails free.
Drug Development Institute's most common email format is Last.F@osu.edu (ex. Doe.J@osu.edu), used for 61% of osu.edu addresses. Drug Development Institute uses 4 email patterns.
| Format | Example | Share of osu.edu |
|---|---|---|
| Last.F@osu.eduMost common | Doe.J@osu.edu | |
| First.Last@osu.edu | John.Doe@osu.edu | |
| Last@osu.edu | Doe@osu.edu | |
| FLast@osu.edu | JDoe@osu.edu |
Browse Drug Development Institute's employee directory (about 6 employees) and reveal verified emails free.
Biotechnology ResearchOhio, United States2-10 Employees
The Drug Development Institute (DDI) is a biotech-oriented research entity embedded within The Ohio State University Comprehensive Cancer Center in Columbus, Ohio. It focuses on advancing cancer research from discovery through early drug development by applying an industry-minded approach to investment and program management, aiming to accelerate translation of innovative findings into potential clinical candidates. The DDI collaborates with university resources and maintains an advisory board of experts with backgrounds in drug discovery, development, and commercialization, while fostering partnerships with pharmaceutical, biotech, and venture capital firms to bridge gaps toward early clinical development. The organization supports its pipeline through targeted investments, strategic management, and access to advanced drug development resources, spanning from initial discovery to preclinical and early clinical steps. Recent broader OSU activities in the news include AI-related research and institutional expansions in the Columbus area, which contextualize the university’s broader research ecosystem in which the DDI operates.
Most common format
Last.F@osu.edu
Example: Doe.J@osu.edu
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.